Glucocerebrosidase (Gaucher disease)
- PMID: 8889578
- DOI: 10.1002/(SICI)1098-1004(1996)8:3<207::AID-HUMU2>3.0.CO;2-6
Glucocerebrosidase (Gaucher disease)
Abstract
Gaucher disease is the most common glycolipid storage disorder, characterized by storage of the glycolipid, glucocerebroside in the liver, spleen, and marrow. The most prevalent form of Gaucher disease is designated type I (MIM 230800). Patients with type I disease may have hepatomegaly, splenomegaly, bone lesions, and less commonly, lung disease, but are free of neurological involvement. Types II (MIM 230900) and III (MIM 2310000), the acute infantile and juvenile forms, respectively, of Gaucher disease, are characterized by the fact that the central nervous system is affected.
Similar articles
-
[From gene to disease; Gaucher disease].Ned Tijdschr Geneeskd. 2005 Sep 24;149(39):2163-6. Ned Tijdschr Geneeskd. 2005. PMID: 16223076 Review. Dutch.
-
Two novel polymorphic sequences in the glucocerebrosidase gene region enhance mutational screening and founder effect studies of patients with Gaucher disease.Hum Genet. 1999 Apr;104(4):293-300. doi: 10.1007/s004390050957. Hum Genet. 1999. PMID: 10369158
-
The role of neurogenetics in Gaucher disease.Arch Neurol. 1993 Nov;50(11):1212-24. doi: 10.1001/archneur.1993.00540110088009. Arch Neurol. 1993. PMID: 8215980 Review.
-
[Gaucher disease: importance of early diagnosis and therapy].Orv Hetil. 2008 Apr 20;149(16):743-50. doi: 10.1556/OH.2008.28337. Orv Hetil. 2008. PMID: 18426721 Review. Hungarian.
-
Type I Gaucher's disease with homozygous R463C mutation without neurological involvement.Haematologia (Budap). 2002;32(4):487-93. Haematologia (Budap). 2002. PMID: 12803123
Cited by
-
Clinical Outcomes of Patients with Chronic Neuropathic Form of Gaucher Disease in the Spanish Real-World Setting: A Retrospective Study.Biomedicines. 2023 Oct 22;11(10):2861. doi: 10.3390/biomedicines11102861. Biomedicines. 2023. PMID: 37893235 Free PMC article.
-
Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula.Orphanet J Rare Dis. 2012 Mar 19;7:17. doi: 10.1186/1750-1172-7-17. Orphanet J Rare Dis. 2012. PMID: 22429443 Free PMC article.
-
Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease.Orphanet J Rare Dis. 2017 May 3;12(1):84. doi: 10.1186/s13023-017-0627-z. Orphanet J Rare Dis. 2017. PMID: 28468677 Free PMC article.
-
Unfolded protein response in Gaucher disease: from human to Drosophila.Orphanet J Rare Dis. 2013 Sep 11;8:140. doi: 10.1186/1750-1172-8-140. Orphanet J Rare Dis. 2013. PMID: 24020503 Free PMC article.
-
The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement.J Inherit Metab Dis. 2003;26(6):513-26. doi: 10.1023/a:1025902113005. J Inherit Metab Dis. 2003. PMID: 14605497 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases